600329 Tianjin Pharmaceutical Da Ren Tang Group Corporation
- 33.70
- +0.79+2.40%
Tianjin Pharmaceutical Da Ren Tang Group Corporation News
TJ Darentang's 2023 Annual Equity Distribution Implementation Announcement
Announcement of Daren Tang's 2023 Profit Distribution Plan
Daren Tang\'s announcement on the judicial freezing of some of the controlling shareholders\' shares
Ta Ren Tang 2019 A-share Restricted Stock Incentive Plan Repurchase Cancellation Implementation Notice
Tat Ren Tang\'s announcement on the fifth repurchase and cancellation of some restricted stock notifications to creditors
Tat Ren Tang\'s announcement on the fourth adjustment of the company\'s 2019 A-share restricted stock plan repurchase price and the fifth repurchase and cancellation of restricted shares that have been granted but have not yet been lifted
Legal opinion of Tianjin Xingtong Law Firm on matters relating to the fourth adjustment of the repurchase price of the 2019 A-share restricted stock incentive plan by Jinyao Daren Tang Group Co., Ltd. and the fifth repurchase and cancellation of some restr
Ta Ren Tang\'s indicative announcement that the controlling shareholder\'s participating shareholders intend to transfer the controlling shareholder\'s shares through a public solicitation of the transferee
Ta Ren Tang 2022 Annual Equity Distribution Implementation Notice
Da Ren Tang 2019 A-share Restricted Stock Incentive Plan Repurchase Cancellation Implementation Notice
Announcement of Da Ren Tang\'s 2022 profit distribution plan
Da Ren Tang's announcement on the third adjustment to the repurchase price of the company's 2019 A-share restricted stock plan and the fourth repurchase cancellation of restricted stocks that have been granted but the restrictions have not yet been lifted
Legal opinion of Tianjin Xingtong Law Firm on matters relating to the third adjustment of the repurchase price of the 2019 A-share restricted stock incentive plan by Jinyao Danentang Group Co., Ltd. and the fourth repurchase and cancellation of some restri
Da Ren Tang's Notice to Creditors on the Fourth Repurchase and Cancellation of Some Restricted Shares
China Yinhe Securities Co., Ltd. Special verification opinions on the deposit and use of funds raised by Tianjin Zhongxin Pharmaceutical Group Co., Ltd. in 2021
Announcement of 2021 profit distribution plan of Zhongxin Pharmaceutical Co., Ltd.
Zhongxin Pharmaceutical: legal opinion of Tianjin Xingtong Law firm on the third repurchase and cancellation of some restricted shares of Tianjin Zhongxin Pharmaceutical Group Co., Ltd.
Zhongxin Pharmaceutical Co., Ltd.: announcement on the implementation of the repurchase and cancellation of the A-share restricted Stock incentive Plan of Zhongxin Pharmaceutical Company in 2019
Legal opinion of Tianjin Xingtong Law firm on the third repurchase and cancellation of some restricted shares of Tianjin Zhongxin Pharmaceutical Group Co., Ltd.
Zhongxin Pharmaceutical Corporation A-share restricted Stock incentive Plan Repurchase cancellation implementation notice in 2019
Analysis
Price Target
No Data
